retatrutide mechanism of action retatrutide clinical trials 2024 2025 Retatrutide—A Game Changer in Obesity Pharmacotherapy 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial

This could prevent you from getting the prescription and delay the start of your weight-loss journey

[DOI] [PubMed] [Google Scholar] 40.McGuire D, Van de Werf F, Armstrong P, et al

As their use expands globally, it becomes increasingly important to evaluate all components of these therapies, not just the active compound." Story Source: Materials provided by Adelaide University

GLP-1, which stands for glucagon-like peptide-1, is a hormone made by the body that helps signal to the brain and the gut that its full and doesnt need to eat any more

Its mechanism is being closely studied in long-term trials, including the SURPASS and SURMOUNT trial series